Model DetailsEye - Harderian gland neoplasm
Model Name |
Eye - Harderian gland neoplasm | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonym |
Harderian gland neoplasm |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Eye - Harderian gland | Female |
0% (0 of 41 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
6.7% (1 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
35.7% (5 of 14 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
8.6% (6 of 70 mice) |
12-36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
2.5% (1 of 40 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
8.2% (6 of 73 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
21.1% (4 of 19 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
8.3% (11 of 132 mice) |
12-36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 16 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
9.1% (2 of 22 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
5.9% (1 of 17 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 1 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
5.4% (3 of 56 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
7.8% (20 of 258 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 43 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
13.3% (2 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
2.7% (2 of 73 mice) |
12-36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
3.6% (1 of 28 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
6.4% (3 of 47 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
17.6% (6 of 34 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
28.6% (2 of 7 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
10.3% (12 of 116 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
9.1% (1 of 11 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
9.5% (2 of 21 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
12.5% (2 of 16 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 8 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
8.9% (5 of 56 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
7.8% (19 of 245 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |